Viking Therapeutics Inc. ($VKTX) has experienced a decline of 65% from its all-time high, raising questions about its current investment potential. Despite the downturn, some investors express cautious optimism about a potential rebound, with discussions indicating interest in acquiring shares at the current price levels, which are nearing $30. The sentiment among investors seems mixed, with some noting the stock's previous popularity as a 'cult stock' and others contemplating whether now is an opportune time to buy.